We found reduced expression of IL10 in TH17 cells (primarily in TH1/17 cells) and increased expression of STAT3 in DN cells in active patients with RRMS (Fig. 7). This evidence concerns the gene STAT3 and relapsing-remitting multiple sclerosis.